Topics

Medicare & Medicaid

Feb 13 | Susan Morse
Health plans doing business in Medicare, Medicaid, and the ACA are being asked to share claims data, and all…
Feb 07 | Jeff Lagasse
Medicare beneficiaries without low-income subsidies can expect to spend $6,894 a year out-of-pocket for treatment of…
Feb 05 | Jeff Lagasse
The findings make a fiscal case for increasing prevention efforts among patents of all ages, not just…
Feb 01 | Jeff Lagasse
Finance leaders are worried about the changing landscape, and many feel unprepared for what's to come.
Feb 01 | Susan Morse
Community Oncology Alliance commends proposal to overhaul what it calls secretive drug rebate system that…
Jan 30 | Susan Morse
For the first time, MA plans may lower cost sharing for drugs such as Naloxone, to treat opioid…
Jan 28 | Jeff Lagasse
Use of AI led to cost reductions including a 25 percent drop in hospital…
Jan 25 | Beth Jones Sanborn
Massive gaps leave practices more dependent on reimbursement from commercial payers and commercial contracts,…
Jan 25 | Jeff Lagasse
Volume increase is the main cost driver, as the number of such procedures has sharply risen across nearly all ages under 65.
Jan 24 | Beth Jones Sanborn
Two cases emerged from whistleblower claims about improper billing related to discounted drug prices and insulin pens.

Pages